Equillium (EQ) Other Non Operating Income (2019 - 2026)
Equillium's (EQ) quarterly Other Non Operating Income came in at $299000.0 in Q1 2026, up 38.43% year-on-year from $216000.0 in Q1 2025, and up 69.89% on a QoQ basis from $176000.0 in Q4 2025.
Equillium (EQ) Other Non Operating Income (2019 - 2026) Analysis & Trends
Equillium (EQ) has 8 years of Other Non Operating Income data on file, last reported at $299000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 38.43% year-over-year to $299000.0 in Q1 2026; TTM through Mar 2026 was $1.3 million, a 434.29% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 1308.05% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $299000.0, up from $176000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for EQ reached as high as $1.3 million in Q4 2022 and fell as low as -$1.6 million in Q4 2023.
- Historically, Other Non Operating Income has averaged $67294.1 across 5 years, with a median of $216000.0 in 2025.
- On a YoY basis, Other Non Operating Income climbed as much as 5927.27% in 2022 and fell as far as 558.62% in 2022.
- Year by year, Other Non Operating Income stood at $1.3 million in 2022, then sank by 222.25% to -$1.6 million in 2023, then climbed by 25.29% to -$1.2 million in 2024, then soared by 114.53% to $176000.0 in 2025, then soared by 69.89% to $299000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $299000.0 in Q1 2026, $176000.0 in Q4 2025, and $345000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Equillium | 242.14 Mn | 242.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 299,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 345,000.00 |
| Jun 30, 2025 | 489,000.00 |
| Mar 31, 2025 | 216,000.00 |
| Dec 31, 2024 | -1.21 Mn |
| Sep 30, 2024 | 672,000.00 |
| Jun 30, 2024 | 568,000.00 |
| Mar 31, 2024 | 57,000.00 |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | 409,000.00 |
| Jun 30, 2023 | 256,000.00 |
| Mar 31, 2023 | -179,000.00 |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | -418,000.00 |
| Jun 30, 2022 | -382,000.00 |
| Mar 31, 2022 | 142,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -163,000.00 |
| Jun 30, 2021 | -58,000.00 |